
FDA Approves Skytrofa for Adult Growth Hormone Deficiency
The FDA has approved Skytrofa® (lonapegsomatropin-tcgd) for treating adults with growth hormone deficiency (GHD). This once-weekly, subcutaneous injection is a pegylated prodrug of somatropin, designed for sustained release of the active hormone. Skytrofa …